A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.

about

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.

Item

http://www.wikidata.org/entity/Q50317754

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@en

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@nl

type

Item

label

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@en

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@nl

prefLabel

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@en

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@nl

P1476

A Prognostic Model Based on Ci ...... Metastatic Colorectal Cancer.

@en

P2093

Chiao-En Wu

http://www.w3.org/2001/XMLSchema#string

Gwo-Jyh Chang

http://www.w3.org/2001/XMLSchema#string

Hung-Chih Hsu

http://www.w3.org/2001/XMLSchema#string

Jason Chia-Hsun Hsieh

http://www.w3.org/2001/XMLSchema#string

Min-Hsien Wu

http://www.w3.org/2001/XMLSchema#string

Pei-Hung Chang

http://www.w3.org/2001/XMLSchema#string

Wen-Chi Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Application of optically-induced-dielectrophoresis in microfluidic system for purification of circulating tumour cells for gene expression analysis- Cancer cell line model

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer.

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis.

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases.

P304

137-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJBS.23182

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wen-Kuan Huang

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29483832

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5821035

http://www.w3.org/2001/XMLSchema#string